Literature DB >> 30603518

Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases.

Dongkyu Kim1, Gun-Sik Cho1, Choongseong Han1,2, Dong-Hyuk Park3, Hee-Kyung Park2, Dong-Hun Woo1, Jong-Hoon Kim4.   

Abstract

Liver failure is one of the main risks of death worldwide, and it originates from repetitive injuries and inflammations of liver tissues, which finally leads to the liver cirrhosis or cancer. Currently, liver transplantation is the only effective treatment for the liver diseases although it has a limitation due to donor scarcity. Alternatively, cell therapy to regenerate and reconstruct the damaged liver has been suggested to overcome the current limitation of liver disease cures. Several transplantable cell types could be utilized for recovering liver functions in injured liver, including bone marrow cells, mesenchymal stem cells, hematopoietic stem cells, macrophages, and stem cell-derived hepatocytes. Furthermore, paracrine effects of transplanted cells have been suggested as a new paradigm for liver disease cures, and this application would be a new strategy to cure liver failures. Therefore, here we reviewed the current status and challenges of therapy using stem cells for liver disease treatments.

Entities:  

Keywords:  Liver failure; Liver regeneration; Secretome; Stem cell transplantation

Year:  2017        PMID: 30603518      PMCID: PMC6171672          DOI: 10.1007/s13770-017-0093-7

Source DB:  PubMed          Journal:  Tissue Eng Regen Med        ISSN: 1738-2696            Impact factor:   4.169


  3 in total

1.  Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian's Disease.

Authors:  Ji Yong Lee; Hyun Soo Kim; Sung Hoon Kim; Han-Soo Kim; Byung Pil Cho
Journal:  Tissue Eng Regen Med       Date:  2020-01-22       Impact factor: 4.169

2.  Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice.

Authors:  Roberta Angioni; Bianca Calì; Vasanthy Vigneswara; Marika Crescenzi; Ana Merino; Ricardo Sánchez-Rodríguez; Cristina Liboni; Martin J Hoogduijn; Philip Noel Newsome; Maurizio Muraca; Francesco Paolo Russo; Antonella Viola
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

Review 3.  Liver Regeneration by Hematopoietic Stem Cells: Have We Reached the End of the Road?

Authors:  Elena Konstantina Siapati; Maria G Roubelakis; George Vassilopoulos
Journal:  Cells       Date:  2022-07-27       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.